Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Matteo Doglio, MD, IRCCS Ospedale San Raffaele, Milan, Italy, discusses the use of CAR T-cells for treating autoimmune diseases. In the future, this novel application of CAR T-cells could change the treatment landscape of autoimmune diseases. This interview took place at the 2nd European CAR T-Cell Meeting in Sitges, Spain.
We use necessary cookies to make this site work. Analytics, preference, and marketing cookies are used only if you choose to allow them. You can change your choice at any time. For more information view our Cookie Policy.